Merge Cardio software. Product Usage: Merge Cardio is a system intended to be used to acquire, store, print, transfer, and archive clinical information including images, Hemodynamic studies and reports, measurements (via import from DICOM Structured Reporting, text files or optical character recognition of measurements captured on images) and cardiology signal (waveform) data.
Publicado el 29 de marzo de 2017 · Inicio del retiro: 22 de septiembre de 2015
Resumen
FDA registra el retiro Z-1517-2017 de dispositivos médicos de Clase II, publicado el 29 de marzo de 2017 e iniciado el 22 de septiembre de 2015. Empresa responsable: Merge Healthcare, Inc.; Estado: Finalizado; Cantidad reportada: 89 sites potentially have the affected software; Lote: Versions 9.0, 9.0.1, 9.0.2, 9.0.3, 9.0.4, 9.0.5, 9.0.6, 9.0.7, and 9.0.8. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Users can merge a device import file with an image study that already has a confirmed report, which may result in including information not present at the time of physician interpretation.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Merge Healthcare, Inc.
- Distribuidor
- US Nationwide Distribution.
- Lote
- Versions 9.0, 9.0.1, 9.0.2, 9.0.3, 9.0.4, 9.0.5, 9.0.6, 9.0.7, and 9.0.8
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAMerge PACS and Merge OrthoPACS, medical imaging diagnostic workstation2 de septiembre de 2026
- FDAMerge OrthoPACS, medical imaging diagnostic workstation12 de agosto de 2026
- FDAMerge PACS, medical imaging diagnostic workstation12 de agosto de 2026
- FDAVERICIS, Merge Cardio, Model/Catalog Number: Version 9.x, Software Version: 9.0.6 and 9.0.8; VERICIS is an26 de marzo de 2025
- FDAPoly Component Trial, UCCS, packaged in the following sizes and configurations: a) Poly Comp Trial - UCCS29 de marzo de 2017
- FDAETEST Ceftazidime TZ256 Foam packaging, Product Name: ETEST Ceftazidime TZ 0.016-256. ETEST is a quantitative29 de marzo de 2017
Preguntas sobre este retiro
¿Merge Cardio software. Product Usage: Merge Cardio is a system intended to be used to acquire, store, print, transfer, and archive clinical information including images, Hemodynamic studies and reports, measurements (via import from DICOM Structured Reporting, text files or optical character recognition of measurements captured on images) and cardiology signal (waveform) data. fue retirado del mercado?
Sí. FDA publicó el retiro Z-1517-2017 el 29 de marzo de 2017. Peligro reportado: Users can merge a device import file with an image study that already has a confirmed report, which may result in including information not present at the time of physician interpretation.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter